These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12271807)

  • 41. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
    Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
    Trials; 2017 May; 18(1):233. PubMed ID: 28545578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A pilot study on the effectiveness of a group-based cognitive-behavioral therapy program for coping with auditory hallucinations].
    Mortan O; Tekinsav Sütcü S; German Köse G
    Turk Psikiyatri Derg; 2011; 22(1):26-34. PubMed ID: 21360353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia.
    Turkington D; Kingdon D; Rathod S; Hammond K; Pelton J; Mehta R
    Br J Psychiatry; 2006 Jul; 189():36-40. PubMed ID: 16816304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.
    Granholm E; Holden JL; Sommerfeld D; Rufener C; Perivoliotis D; Mueser K; Aarons GA
    Trials; 2015 Sep; 16():438. PubMed ID: 26424639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study.
    Klingberg S; Herrlich J; Wiedemann G; Wölwer W; Meisner C; Engel C; Jakobi-Malterre UE; Buchkremer G; Wittorf A
    J Nerv Ment Dis; 2012 Jul; 200(7):569-76. PubMed ID: 22759932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.
    Turkington D; Kingdon D; Turner T;
    Br J Psychiatry; 2002 Jun; 180():523-7. PubMed ID: 12042231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-year follow-up of cognitive--behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia.
    Tarrier N; Kinney C; McCarthy E; Humphreys L; Wittkowski A; Morris J
    J Consult Clin Psychol; 2000 Oct; 68(5):917-22. PubMed ID: 11068978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Group treatment of auditory hallucinations. Exploratory study of effectiveness.
    Wykes T; Parr AM; Landau S
    Br J Psychiatry; 1999 Aug; 175():180-5. PubMed ID: 10627803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychological treatments for early psychosis can be beneficial or harmful, depending on the therapeutic alliance: an instrumental variable analysis.
    Goldsmith LP; Lewis SW; Dunn G; Bentall RP
    Psychol Med; 2015 Aug; 45(11):2365-73. PubMed ID: 25805118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The management of schizophrenia: cognitive behavioural therapy.
    Siddle R; Kingdon D
    Br J Community Nurs; 2000 Jan; 5(1):20-5. PubMed ID: 12784789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
    Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
    Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.
    Klingberg S; Wittorf A; Herrlich J; Wiedemann G; Meisner C; Buchkremer G; Frommann N; Wölwer W
    Eur Arch Psychiatry Clin Neurosci; 2009 Nov; 259 Suppl 2():S149-54. PubMed ID: 19876673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The evolution of cognitive behavior therapy for schizophrenia: current practice and recent developments.
    Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):865-73. PubMed ID: 19661198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
    Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
    Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive-behavioral therapy for schizophrenia: a review.
    Turkington D; Dudley R; Warman DM; Beck AT
    J Psychiatr Pract; 2004 Jan; 10(1):5-16. PubMed ID: 15334983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is symptomatic improvement in clinical trials of cognitive-behavioral therapy for psychosis clinically significant?
    Gaudiano BA
    J Psychiatr Pract; 2006 Jan; 12(1):11-23. PubMed ID: 16432441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
    Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
    Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized controlled trial of cognitive-motivational therapy program (PIPE) for the initial phase of schizophrenia: Maintenance of efficacy at 5-year follow up
    Palma C; Farriols N; Frías A; Cañete J; Gomis O; Fernández M; Alonso I; Signo S
    Psychiatry Res; 2019 Mar; 273():586-594. PubMed ID: 30716598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.